FindTrial
Sign In

Screening for eye inflammation in children suffering from joint related diseases

Prevalence Of Uveitis in Pediatric Autoimmune Rheumatic Diseases (AIRD) and Autoinflammatory Diseases. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/07/091404
Enrollment
140
Registered
2025-07-22
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H201- Chronic iridocyclitis

Interventions

Intervention1: Nil: Nil

Sponsors

L V Prasad Eye Institute
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children aged 2-16 years diagnosed with any autoimmune rheumatic disease (Juvenile Idiopathic Arthritis (JIA), Autoinflammatory syndromes)

Exclusion criteria

Exclusion criteria: 1.Children with infectious diseases. 2.Children with significant comorbidities unrelated to rheumatic conditions. 3.Children with poor vision due to other causes.

Design outcomes

Primary

MeasureTime frame
1.Prevalence of uveitis in pediatric rheumatic and autoinflammatory disease patients. 2.Types of uveitis (anterior, intermediate, posterior, or panuveitis) in subsets of pediatric rheumatic diseases. Timepoint: 3 Months, 6 Months, 12 Months,18 Months, 24 Months—

Secondary

MeasureTime frame
1.Association between levels of inflammatory markers (e.g., ESR, CRP) and the occurrence and severity of uveitis. 2.Correlation between disease activity scores in rheumatic diseases and uveitis occurrence. Timepoint: 3 Months, 6 Months, 12 Months,18 Months, 24 Months—

Countries

India

Contacts

Public ContactDrShabtab Nasir

L V Prasad Eye Institute

shabtab.nasir@lvpei.org8879335518

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026